ASHP Guidelines on Preventing Diversion of Controlled Substances.

Clark, John; Fera, Toni; Fortier, Christopher; Gullickson, Kristine; Hays, Amanda; Murdaugh, Lee; Ogden, Ricky; O'Neal, Brian; Rush, Jordan; Vest, Tyler

Clark, John; Fera, Toni; Fortier, Christopher; Gullickson, Kristine; Hays, Amanda; Murdaugh, Lee; Ogden, Ricky; O'Neal, Brian; Rush, Jordan; Vest, Tyler.

Afiliación

Clark J; University of Michigan Health, Ann Arbor, MI, and University of Michigan College of Pharmacy, Ann Arbor, MI, USA.
Fera T; Independent Healthcare Consultant, Pittsburgh, PA, USA.
Fortier C; Massachusetts General Hospital, Boston, MA, USA.
Gullickson K; Allina Health Abbott Northwestern Hospital, Minneapolis, MN, USA.
Hays A; Becton, Dickinson and Company, San Diego, CA, USA.
Murdaugh L; Cardinal Health, Dublin, OH, USA.
Ogden R; Children's Mercy Kansas City, Kansas City, MO, USA.
O'Neal B; Children's Mercy Kansas City, Kansas City, MO, USA.
Rush J; UNC Health, Chapel Hill, NC, USA.
Vest T; Duke University Hospital, Durham, NC, and University of North Carolina at Chapel Hill Eshelman School of Pharmacy, Chapel Hill, NC, USA.

Am J Health Syst Pharm ; 79(24): 2279-2306, 2022 12 05.

Article en En | MEDLINE | ID: mdl-36208462

Asunto(s)

Sustancias Controladas; Control de Medicamentos y Narcóticos; Humanos; Analgésicos Opioides/efectos adversos

Palabras clave

controlled substances; documentation; facility regulation and control; patient safety; prescription drug diversion; quality improvement

Texto completo

Añadir a Mi BVS

Imprimir

XML

PubMed Links

Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Control de Medicamentos y Narcóticos / Sustancias Controladas Tipo de estudio: Guideline Límite: Humans Idioma: En Revista: Am J Health Syst Pharm Asunto de la revista: FARMACIA / HOSPITAIS Año: 2022 Tipo del documento: Article País de afiliación: Estados Unidos Pais de publicación: Reino Unido

Texto completo

Añadir a Mi BVS

Imprimir

XML

PubMed Links

Buscar en Google